July 25, 2014 12:36 AM ET

Pharmaceuticals

Company Overview of BiPar Sciences, Inc.

Company Overview

BiPar Sciences, Inc., a biopharmaceutical company, offers development and commercialization tumor-selective drugs for cancer patients. It offers BSI-201, a poly ADP-ribose polymerase (PARP) inhibitor for metastatic triple negative breast cancer, ovarian cancer, and other malignancies; BSI-401, a follow-on PARP inhibitor candidate for pancreatic cancer; and BSI-301, an iodothyronine program with anti-tubulin properties. The company was founded in 2002 and is headquartered in Brisbane, California. As of April 27, 2009, BiPar Sciences, Inc. operates as a subsidiary of Sanofi.

1000 Marina Boulevard

Suite 550

Brisbane, CA 94005

United States

Founded in 2002

Phone:

650-635-6050

Fax:

650-635-6057

Key Executives for BiPar Sciences, Inc.

Co-Founder
Co-Founder and Member of Scientific & Clinical Advisory Board
Chief Executive Officer of Sanofi-Aventis
Age: 54
Corporate Secretary and Director
Age: 55
Legal Counsel
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
MedPointe Healthcare, Inc. United States
Ampere Life Sciences, Inc. United States
HempCon, Inc. United States
FASgen, Inc. United States
Olympian Labs, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BiPar Sciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.